The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

Nature Medicine

Volumn 14, Issue 11, 2008, Pages 1271-1277

  Bonci, Désirée ^a   Coppola, Valeria ^a   Musumeci, Maria ^a   Addario, Antonio ^a   Giuffrida, Raffaella ^b   Memeo, Lorenzo ^b   D'Urso, Leonardo ^c   Pagliuca, Alfredo ^a   Biffoni, Mauro ^a   Labbaye, Catherine ^a   Bartucci, Monica ^a   Muto, Giovanni ^c   Peschle, Cesare ^a,d   De Maria, Ruggero ^a,b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Mediterranean Institute of Oncology   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MICRORNA; PROTEIN BCL 2; WNT3A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE CLUSTER; GROWTH DISORDER; HUMAN; HUMAN CELL; HYPERPLASIA; MALE; MIR 15A GENE; MIR 16 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CYCLIN D1; HUMANS; MALE; MICE; MICRORNAS; MULTIGENE FAMILY; ONCOGENE PROTEINS; PROSTATIC NEOPLASMS; WNT PROTEINS;

MUS;

EID: 55549114664     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1880     Document Type: Article

References (33)

1. Jemal, A. et al. Cancer statistics, 2006. CA Cancer J. Clin. 56, 106-130 (2006).
2. Loberg, R.D., Logothetis, C.J., Keller, E.T. & Pienta, K.J. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype. J. Clin. Oncol. 23, 8232-8241 (2005).
3. Pienta, K.J. & Smith, D.C. Advances in prostate cancer chemotherapy: a new era begins. CA Cancer J. Clin. 55, 300-318 (2005).
4. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
5. Care, A. et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13, 613-618 (2007).
6. Calin, G.A. et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353, 1793-1801 (2005).
7. Calin, G.A. et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101, 2999-3004 (2004).
8. Esquela-Kerscher, A. & Slack, F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269 (2006).
9. Calin, G.A. et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 99, 15524-15529 (2002).
10. Dong, J.T., Boyd, J.C. & Frierson, H.F. Jr. Loss of heterozygosity at 13q14 and 13q21 in high-grade, high-stage prostate cancer. Prostate 49, 166-171 (2001).
11. Hyytinen, E.R., Frierson, H.F., Jr., Boyd, J.C., Chung, L.W. & Dong, J.T. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer. Genes Chromosom. Cancer 25, 108-114 (1999).
12. Cimmino, A. et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA 102, 13944-13949 (2005).
13. Yin, Z. et al. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene 18, 7576-7583 (1999).
14. Ebert, M.S., Neilson, J.R. & Sharp, P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721-726 (2007).
15. Nupponen, N.N., Hyytinen, E.R., Kallioniemi, A.H. & Visakorpi, T. Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization. Cancer Genet. Cytogenet. 101, 53-57 (1998).
16. Bonci, D. et al. 'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther. 10, 630-636 (2003).
17. Felli, N. et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl. Acad. Sci. USA 102, 18081-18086 (2005).
18. Follenzi, A., Ailles, L.E., Bakovic, S., Geuna, M. & Naldini, L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25, 217-222 (2000).
19. Clevers, H. Wnt/β-catenin signaling in development and disease. Cell 127, 469-480 (2006).
20. Dhanasekaran, S.M. et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822-826 (2001).
21. Sherr, C.J. Cancer cell cycles. Science 274, 1672-1677 (1996).
22. Almeida, M., Han, L., Bellido, T., Manolagas, S.C. & Kousteni, S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J. Biol. Chem. 280, 41342-41351 (2005).
23. Yun, M.S., Kim, S.E., Jeon, S.H., Lee, J.S. & Choi, K.Y. Both ERK and Wnt/b-catenin pathways are involved in WNT3A-induced proliferation. J. Cell Sci. 118, 313-322 (2005).
24. Bello, D., Webber, M.M., Kleinman, H.K., Wartinger, D.D. & Rhim, J.S. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 18, 1215-1223 (1997).
25. Krutzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005).
26. Tolcher, A.W. et al. A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer. Clin. Cancer Res. 11, 3854-3861 (2005).
27. Zimmermann, T.S. et al. RNAi-mediated gene silencing in non-human primates. Nature 441, 111-114 (2006).
28. Navone, N.M., Olive, M. & Troncoso, P. Isolation and culture of prostate cancer cell lines. Methods Mol. Med. 88, 121-132 (2004).
29. Nelson, P.T. et al. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA 12, 187-191 (2006).
30. Lewis, B.P., Burge, C.B. & Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
31. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P. & Burge, C.B. Prediction of mammalian microRNA targets. Cell 115, 787-798 (2003).
32. John, B. et al. Human MicroRNA targets. PLoS Biol. 2, e363 (2004).
33. Krek, A. et al. Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500 (2005).